Carolyn Milligan
Women's Health · Dallas, TXNPI 1699775890
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$273
- Merck$220
- Novo Nordisk$218
- Bayer$212
- Lilly USA, LLC$190
- Boehringer Ingelheim$163
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,375100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $273 |
| Merck | 11 | $220 |
| Novo Nordisk | 13 | $218 |
| Bayer | 11 | $212 |
| Lilly USA, LLC | 12 | $190 |
| Boehringer Ingelheim | 8 | $163 |
| Novartis | 8 | $137 |
| Esperion Therapeutics, Inc. | 5 | $105 |
| Dexcom, Inc. | 6 | $95 |
| Amarin Pharma, Inc. | 4 | $93 |
| Sumitomo Pharma America, Inc. | 2 | $92 |
| Zealand Pharma US, Inc. | 4 | $75 |
| Mannkind Corporation | 4 | $74 |
| AstraZeneca | 4 | $62 |
| Sequel Med Tech, LLC | 2 | $59 |
| Corcept Therapeutics | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Insulet Corporation | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Seqirus USA Inc | 1 | $20 |
| GSK | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Amgen | 1 | $16 |
| Pfizer | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,375 in reported general payments places this provider in the 90th percentile of 609 women's health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 57 | $82,688 |
| MounjaroTirzepatide | 44 | $49,029 |
| OzempicSemaglutide | 39 | $42,049 |
| FarxigaDapagliflozin Propanediol | 37 | $41,141 |
| EliquisApixaban | 16 | $16,529 |
| Repatha SureclickEvolocumab | 23 | $15,752 |
| VascepaIcosapent Ethyl | 14 | $11,746 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $5,822 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,843 |
| Rosuvastatin Calcium | 198 | $2,389 |
| Ezetimibe | 142 | $2,230 |
| Gabapentin | 77 | $2,004 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 13 | $1,973 |
| SynthroidLevothyroxine Sodium | 17 | $1,754 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $1,485 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $163 | $82,68857 claims |
| Lilly USA, LLCMounjaro | $190 | $49,02944 claims |
| AstraZenecaFarxiga, Symbicort | $62 | $44,98450 claims |
| Novo NordiskOzempic | $218 | $42,04939 claims |
| PfizerEliquis, Paxlovid | $13 | $17,95827 claims |
| AbbVieSynthroid | $273 | $1,75417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 609 women's health providers in Texas.
Other women's health in Dallas
- Christina HicksDallas$8K
- Sarah GoughDallas$5K
- Barbara MaukDallas$4K
- Brianna AcostaDallas$3K
- Annette BaconDallas$3K
- Kris HumphreyDallas$3K
- Vicki DonoskyDallas$3K
- Mahnaz MostofiDallas$2K
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.